| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |